Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects

NCT02660736 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Albiglutide Liquid Auto-injector
DRUG: Albiglutide Lyophilized DCC Pen Injector
DRUG: Placebo Liquid Auto-injector
DRUG: Placebo Lyophilized DCC Pen injector

Sponsor

GlaxoSmithKline